Catalyst Pharmaceutical Partners (CPRX)
Catalyst Pharmaceutical Partners Liabilities: 2.272M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
CPRX Liabilities Rankings
| Overall | 98th percentile | 77 of 4384 |
| Sector | 95th percentile | 22 of 504 in Healthcare |
| Industry | 92nd percentile | 1 of 14 in Drugs - Generic |
CPRX Liabilities Range, Past 5 Years
| Minimum | 0.3137M | Dec 2010 |
| Maximum | 2.489M | Dec 2011 |
| Average | 0.8133M |
About Total Liabilities
Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.
Total liabilities is a line item on the balance sheet.
Learn More
You may also be interested in these CPRX related companies
CPRX News
Notable 52-Week Highs and Lows of the Day 05/24: (LCC) (PETM) (DUK) High; (NTAP) (RIMM) (CPRX) Low
May 24, 2:14PM Street Insider
May 24, 2:14PM Street Insider
Catalyst Pharmaceutical Partners Prices Underwritten Offering; 6M Units at $0.80/Unit
May 24, 8:45AM Benzinga
May 24, 8:45AM Benzinga
Catalyst Pharma (CPRX) Shares Jump 20% as CPP-115 Safe, Well Tolerated Across All Doses
May 22, 8:10AM Street Insider
May 22, 8:10AM Street Insider
Catalyst Pharmaceutical (CPRX) Reports Encouraging Data from CPP-115 Phase Ia
May 22, 8:05AM Street Insider
May 22, 8:05AM Street Insider
Catalyst Pharmaceutical Partners Announces First Quarter 2012 Financial Results
May 16, 8:03AM GlobeNewswire
May 16, 8:03AM GlobeNewswire
Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2011 Financial Results
Apr 02, 8:03AM GlobeNewswire
Apr 02, 8:03AM GlobeNewswire
$CPRX forms bearish "Descending Continuation Triangle" chart pattern. http://stks.co/31zj
about 67 days ago by RecogniaEvents
about 67 days ago by RecogniaEvents
Catalyst Pharmaceutical Partners to Present at 24th Annual ROTH Conference
Mar 06, 8:03AM GlobeNewswire
Mar 06, 8:03AM GlobeNewswire
Catalyst Pharmaceutical Partners to Present at Cowen and Company's 32nd Annual Health Care Conference
Feb 28, 8:03AM GlobeNewswire
Feb 28, 8:03AM GlobeNewswire
$GNOM, $ESTE, $CPRX CRWENewswire Stocks In Action - http://stks.co/2NpV
about 105 days ago by pakistock
about 105 days ago by pakistock
Catalyst Pharmaceutical Partners to Present CPP-115 Progress at the 2012 Epilepsy Pipeline Update Conference
Jan 31, 8:03AM GlobeNewswire
Jan 31, 8:03AM GlobeNewswire
Catalyst Pharma (CPRX) Investigational Drug CPP-115 Gets FDA Fast-Track Designation
Dec 20, 10:17AM Street Insider
Dec 20, 10:17AM Street Insider
$CPRX Announces FDA Designation of CPP-115 as Fast-Track Development Program
about 160 days ago by Benzinga
about 160 days ago by Benzinga
Catalyst Pharmaceutical Partners, Inc. Announces FDA Designation of CPP-115 as a Fast Track Development Program
Dec 20, 10:13AM GlobeNewswire
Dec 20, 10:13AM GlobeNewswire
Catalyst Pharm announces commencement of Phase I(a) safety study for CPP-115
Dec 13, 8:19AM theflyonthewall.com
Dec 13, 8:19AM theflyonthewall.com
Catalyst Pharmaceutical (CPRX) Commences CPP-115 Phase Ia Safety Study
Dec 13, 8:03AM Street Insider
Dec 13, 8:03AM Street Insider
Catalyst Pharmaceutical Partners, Inc. Announces Commencement of Phase I(a) Safety Study for CPP-115
Dec 13, 8:03AM GlobeNewswire
Dec 13, 8:03AM GlobeNewswire
Catalyst Pharmaceutical Partners Promotes Alicia Grande to Vice President and Chief Financial Officer
Dec 02, 8:03AM GlobeNewswire
Dec 02, 8:03AM GlobeNewswire
Catalyst Pharmaceutical Partners Announces Third Quarter 2011 Financial Results
Nov 15, 8:03AM GlobeNewswire
Nov 15, 8:03AM GlobeNewswire
Catalyst Pharmaceutical (CPRX) Names Richard P. Rieger as Vice President, Commercial Operations
Nov 14, 8:07AM Street Insider
Nov 14, 8:07AM Street Insider
$cprx highs of day . takes out yest highs 1.75 goes to 1.95 then ___ :)
about 356 days ago by danshep55
about 356 days ago by danshep55
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CPRX | 0.561 | -0.01 | -1.58% | 13.86M |
| CPRT | 27.06 | -0.18 | -0.66% | 3.523B |
| CPO | 52.23 | -0.06 | -0.11% | 3.986B |
| CPNO | 26.64 | +0.19 | +0.72% | 1.923B |
| CPN | 16.91 | -0.01 | -0.06% | 8.139B |
| CPLP | 7.54 | +0.03 | +0.40% | 523.05M |
| DDS | 69.49 | -0.32 | -0.46% | 3.436B |
| DDR | 13.89 | -0.11 | -0.79% | 3.851B |
| DDIC | 12.98 | -0.01 | -0.08% | 265.83M |
| DDG | 36.25 | +0.15 | +0.42% |